Poly Cystic Ovarian Syndrome. E28.2: Polycystic Ovarian Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Periodic Disorders (Oligomenorrhea or Amenorrhea Patients). Hirsutism, Infertility LH / FSH Ratio Increased Ultrasound View of Ovary Size and Multiple Follicles 2-10 mm in Size Normal Sperm Analysis Normal Thyroid Function and Prolactin Levels Natural Hystero Salpingography No Endometriosis
Exclusion criteria
Exclusion criteria: Non-Ovulatory Infertility Factors Male Factor Infertility Pelvic Organ Damage Congenital Adrenal Hyperplasia Thyroid Dysfunction Cushing's Syndrome Severe or Renal Liver Diseases Active Gastric Ulcer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of Biochemical Markers. Timepoint: Before and 8 Weeks after Drug Administration. Method of measurement: Elisa Kit.;Stress Oxidative Level. Timepoint: 8 Weeks. Method of measurement: Laboratory Kits.;Oocyte and Embryo Quality. Timepoint: 8 Weeks. Method of measurement: Shape and Morphology. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pregnancy Rate. Timepoint: 8 Weeks. Method of measurement: Laboratory Kits. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iranian academic center for education culture and research